Air Quality: Tips To Limit Your Risk

Pulmonology: Clinical Research Program

Banner

Pulmonology: Clinical Studies Open For Enrollment

 

A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants with Severe Asthma including Several Under-Studied Populations in the United States (PASSAGE).

Eligibility

  • 12 years of age or older
  • Asthma diagnosis for at least past 12 months
  • Use of medium to high dose inhaled corticosteroids for at least 12 months as well as an additional asthma maintenance controller
  • Two or more asthma exacerbations in the past 12 months
  • Not using biologics in the past four months
  • No severe COPD

Enrollment Status: Enrolling

Study Information

ClinicalTrials.gov | NCT05329194

Principal Investigator

Dr. Sankaran Krishnan

Contact for Study Screening

rwilliam11@nymc.edu

 

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)

Eligibility

  • Diagnosis of Cystic Fibrosis
  • No history of transplant
  • No exacerbations in past two weeks

Enrollment Status: Enrolling

Study Information

ClinicalTrials.gov | NCT05639556

Principal Investigator

Dr.Allen Dozer

Contact for Study Screening

rwilliam11@nymc.edu